MIRA INFORM REPORT

 

 

Report Date :

20.12.2014

 

IDENTIFICATION DETAILS

 

Name :

DATWYLER PHARMA PACKAGING INDIA PRIVATE LIMITED

 

 

Formerly Known As :

HELVOET PHARMA INDIA OPERATIONS PRIVATE LIMITED

 

 

Registered Office :

Plot No. 5, Khandala, Sez MIDC, Village Kesurdi, District Satara – 412801, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

05.12.2009

 

 

Com. Reg. No.:

144482

 

 

Capital Investment / Paid-up Capital :

Rs. 550.590 Millions

 

 

CIN No.:

[Company Identification No.]

U25203PN2009PTC144482

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AADCN1330Q

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

The company is engaged in business of pharma packaging.

 

 

No. of Employees :

Information declined by the management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (28)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is a part of “Datwyler Group”. It is an established company having moderate track.

 

Management has reported consecutive losses leading to accumulation of the same.

 

However, trade relations are seems to be fair. Business is active. Payment terms are reported as slow.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION DENIED

 

MANAGEMENT NON CO-OPERATIVE

 

CONTACT NO. : 91-2162-398239

 

LOCATIONS

 

Registered Office :

Plot No. 5, Khandala, Sez MIDC, Village Kesurdi, District Satara – 412801, Maharashtra, India 

Tel. No.:

91-2162-398239

Fax No.:

Not Available

E-Mail :

Pharma@datwyler.com

devendra.mishra@datwyler.com

Website :

http://www.datwyler.com

 

 

/DIRECTORS

 

AS ON 17.09.2014

 

Name :

Dirk Leonardus M Borghs

Designation :

Director

Address :

Acacialaan 37 2460 Kasterlee, NA, Belgium

Date of Birth/Age :

03.11.1963

Date of Appointment :

03.04.2010

DIN No.:

02919667

 

 

Name :

Willy Belmans

Designation :

Director

Address :

Eikenboomlaan 20, 2450 Meerhout, Meerhout, Na, Belgium

Date of Birth/Age :

22.02.1958

Date of Appointment :

03.04.2010

DIN No.:

02919687

 

 

Name :

Guido L M Wallraff

Designation :

Director

Address :

Terlinden 184, 1785 Merchtem, Merchtem, Na, Belgium

Date of Birth/Age :

04.11.1963

Date of Appointment :

03.04.2010

DIN No.:

02964217

 

 

Name :

Rahul Devaprasad Dev

Designation :

Director

Address :

Rose Parade Kondhawa KD, BL- C4, Near- Sai Dwarkamai SOC, Pune-411048, Maharashtra, India

Date of Birth/Age :

15.02.1969

Date of Appointment :

15.10.2012

DIN No.:

06400766

 

 

Name :

Dirk Lambrecht

Designation :

Additional director

Address :

Aeschrain 2B, 6318 Walchwil, Switzerland, 6318, , Switzerland

Date of Birth/Age :

12.12.1960

Date of Appointment :

15.01.2014

DIN No.:

06752969

 

 

Name :

Rolf Kronenberg

Designation :

Additional director

Address :

Schutzenstrasse 52,, 6430 Schwyz, Reiden LU, 6430, , Switzerland

Date of Birth/Age :

20.12.1960

Date of Appointment :

15.01.2014

DIN No.:

06752979

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 17.09.2014

 

Names of Shareholders

 

No. of Shares

Matrijzenmakerji ‘MARO’ BV

 

22150683

Helvoet Pharma Belgium NV

 

2162

Daetwyler Pharma Pack Holding AG

 

43470508

 

 

 

Total

 

65623353

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 17.09.2014

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

The company is engaged in business of pharma packaging.

 

 

Products :

Item Code No.

Product Description

70109000

Pharma Packaging

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

 

PRODUCTION STATUS : NOT DIVULGED

 

 

GENERAL INFORMATION

 

 

Suppliers :

Not Divulged

 

 

Customers :

Not Divulged

 

 

No. of Employees :

Information declined by the management.  

 

 

Bankers :

BNP Paribas, 20, Collyer Quay,, #01-01 Tung Centre,, Singapore - 049319, Singapore

 

 

Facilities :

Secured Loan

31.03.2014

(Rs. in Millions)

31.03.2013

(Rs. in Millions)

Long-term Borrowings

 

 

Term loans from banks

411.950

580.250

Short-term borrowings

 

 

Working capital loans from banks

262.865

16.853

Total

674.815

597.103

 

 

 

 

Banking Relations :

 

 

 

Auditors :

 

Name :

S R B C and Company LLP

Chartered Accountants

Address :

Yerwada Pune

PAN No.:

ACHFS9117R

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Fellow Subsidiary company :

  • Datwyler Pharma Packaging Belgium NV
  • Datwyler Pharma Packaging Italy Srl
  • Datwyler Pharma Packaging USA Inc
  • Datwyler Pharma Packaging International NV
  • Datwyler IT Services AG
  • Daetwyler Pharma Pack Holding AG

 

 

CAPITAL STRUCTURE

 

AS ON 17.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

71,000,000

Equity Shares

Rs.10/- each

Rs.710.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

65,623,353

Equity Shares

Rs.10/- each

Rs.656.234 Millions

 

 

 

 

 

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

71,000,000

Equity Shares

Rs.10/- each

Rs.710.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5,50,58,995

Equity Shares

Rs.10/- each

Rs. 550.590 Millions

 

 

 

 

 

 

 


 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

550.590

550.590

550.590

(b) Reserves & Surplus

(612.331)

(248.820)

0.000

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

156.353

0.000

0.000

Total Shareholders’ Funds (1) + (2)

94.612

301.770

550.590

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1252.430

980.230

696.700

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.363

Total Non-current Liabilities (3)

1252.430

980.230

697.063

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

262.865

16.853

0.000

(b) Trade payables

106.472

74.511

19.727

(c) Other current liabilities

305.738

169.936

90.024

(d) Short-term provisions

3.525

0.577

0.000

Total Current Liabilities (4)

678.600

261.877

109.751

 

 

 

 

TOTAL

2025.642

1543.877

1357.404

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1434.680

1316.112

49.712

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

60.458

71.868

795.734

(iv) Intangible assets under development

0.000

0.000

0.691

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

91.149

18.050

52.826

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

1586.287

1406.030

898.963

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

235.002

88.238

0.000

(c) Trade receivables

159.052

13.516

0.000

(d) Cash and cash equivalents

36.992

32.961

270.912

(e) Short-term loans and advances

8.309

3.132

1.291

(f) Other current assets

0.000

0.000

186.238

Total Current Assets

439.355

137.847

458.441

 

 

 

 

TOTAL

2025.642

1543.877

1357.404

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Income

663.587

14.442

186.238

 

Other Income

0.091

7.707

 NA

 

TOTAL

663.678

22.149

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

TOTAL

1027.189

228.622

NA

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

(363.511)

(206.473)

NA

 

 

 

 

 

Less

TAX

0.000

42.347

NA

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

(363.511)

(248.820)

NA

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

638.887

13.434

 NIL

 

TOTAL EARNINGS

638.887

13.434

NIL

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

 6.60

 --

--

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin PAT/ Sales

(%)

(54.78)

(1722.89)

NA

 

 

 

 

 

PBIDT / Sales

(%)

(54.78)

(1429.67)

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(18.50)

(14.03)

NA

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(3.84)

(0.68)

NA

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

16.02

3.30

1.27

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.65

0.53

4.18

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

550.590

550.590

550.590

Reserves & Surplus

0.000

(248.820)

(612.331)

Share Application money pending allotment

0.000

0.000

156.353

Net worth

550.590

301.770

94.612

 

 

 

 

long-term borrowings

696.700

980.230

1252.430

Short term borrowings

0.000

16.853

262.865

Total borrowings

696.700

997.083

1515.295

Debt/Equity ratio

1.265

3.304

16.016

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

186.238

14.442

663.587

 

 

(92.245)

4,494.841

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

186.238

14.442

663.587

Profit/Loss

0.000

(248.820)

(363.511)

 

0.00%

(1722.89%)

(54.78%)

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

CURRENT MATURITIES OF LONG-TERM DEBT DETAILS:

 

Particulars

31.03.2014

31.03.2013

31.03.2012

 

(Rs. In Millions)

Current maturities of long-term debt

274.633

116.050

0.000

 

 

 

 

Total

274.633

116.050

0.000

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last two years

Yes

12]

Profitability for last two years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOAN

 

PARTICULARS

31.03.2014

(Rs. in Millions)

31.03.2013

(Rs. in Millions)

Long-term Borrowings

 

 

Term loans from banks

840.480

399.980

Total

840.480

399.980

 

 

CORPORATE INFORMATION

The Company was incorporated on December 5 2009 and is in the business of pharma packaging The Company is a subsidiary of Daetwyler Pharma Pack Holding AG Switzerland

 

Note :

Datwyler Pharma Packaging India Private Limited (formerly known as Helvoet Pharma India Operations Private Limited) (the Company) was incorporated on December 5 2009 and is in the business of Pharma Packaging. The Company is a subsidiary of Daetwyler Pharma Pack Holding AG Switzerland.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.07

UK Pound

1

Rs.98.73

Euro

1

Rs.77.46

 

 

INFORMATION DETAILS

 

Information Gathered by :

HTL

 

 

Analysis Done by :

SUB

 

 

Report Prepared by :

SNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

----

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

28

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.